PeptiDream (PPTDF) Stock Price, News & Analysis

Company Overview

PeptiDream Inc. (OTCMKTS:PPTDF) is a Tokyo-based biopharmaceutical company specializing in the discovery and development of peptide-based therapeutics. Since its founding in 2006, the company has built a proprietary Peptide Discovery Platform System (PDPS) that combines encoded peptide libraries with high-throughput screening to identify new macrocyclic and constrained peptides. These compounds are designed to bind with high specificity and affinity to challenging targets, including protein–protein interactions that are often undruggable by conventional small molecules.

The company’s core business model centers on collaborating with global pharmaceutical and biotechnology partners, granting access to its PDPS for early‐stage drug discovery programs. PeptiDream has established alliances with leading industry players across North America, Europe and Asia, leveraging its platform to generate candidate peptides against a wide range of therapeutic targets, from oncology to metabolic and infectious diseases. In addition to partnership revenues, PeptiDream maintains its own internal pipeline of preclinical assets that utilize its platform’s unique capabilities.

Headquartered in Tokyo, PeptiDream operates research facilities in Japan, with business development teams engaged worldwide to support collaborative research and licensing agreements. The company is led by Chief Executive Officer Nobuji Tsukada, whose experience in pharmaceutical R&D and strategic partnerships has guided PeptiDream’s growth in the peptide therapeutics arena. Under his leadership, PeptiDream continues to refine its technology platform and expand its partner network, aiming to bring novel peptide drugs into clinical development and ultimately to patients in need.

Key Stats

• Today's Range: $11.10 to $11.10
• 50-Day Range: $10.33 to $11.81
• 52-Week Range: $10.00 to $13.75
• Volume: N/A
• Average Volume: 850 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PPTDF Stock Analysis - Frequently Asked Questions

How have PPTDF shares performed this year?

PeptiDream's stock was trading at $17.85 at the start of the year. Since then, PPTDF stock has decreased by 37.8% and is now trading at $11.0980.

How do I buy shares of PeptiDream?

Shares of PPTDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/16/2025
• Next Earnings (Estimated): 11/13/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PPTDF
• CIK: N/A
• Web: www.peptidream.com
• Phone: 81-4-4270-1300
• Fax: N/A
• Employees: 603
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A